BioRestorative Therapies raises $1.085M in registered direct offering at $1.60/share; warrants at $2.75

BioRestorative Therapies, Inc.

Registered direct offering of 678,125 shares at $1.60/share, gross proceeds $1.085M; closing expected Oct 8, 2025.
Concurrent private placement of warrants for 508,594 shares at $2.75 exercise price, 75% warrant coverage, exercisable after 6 months for 5 years.
Offering priced at $1.60/share, above October 3 close of $1.50.
Net proceeds to fund BRTX-100 clinical trials, ThermoStem R&D, biocosmeceuticals platform, and working capital.
CEO notes participation from largest institutional shareholder and management team.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.